학술논문

Duvelisib Eliminates CLL B Cells, Impairs CLL-Supporting Cells, and Overcomes Ibrutinib Resistance in a Xenograft Model
Document Type
Journal
Source
CLINICAL CANCER RESEARCH; MAY 15 2023, 29 10, p1984-p1995, 12p.
Subject
Language
English
ISSN
15573265